Publications by authors named "Maximilian Pistor"

Claim this Profile
R
Reliable brain morphometry from contrast-enhanced T1w-MRI in patients with multiple sclerosis.
Michael Rebsamen, Richard McKinley, Piotr Radojewski, Maximilian Pistor, Christoph Friedli

Hum Brain Mapp· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System.
Maximilian Pistor, Robert Hoepner, Andreas G F Hoepner, Yanan Lin, Simon Jung

Ther Adv Neurol Disord· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort.
Maximilian Pistor, Helly Hammer, Anke Salmen, Robert Hoepner, Christoph Friedli

CNS Neurosci Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System.
Maximilian Pistor, Andreas G F Hoepner, Yanan Lin, Simon Jung, Claudio L Bassetti

Ann Rheum Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses.
Brian T Wipke, Robert Hoepner, Katrin Strassburger-Krogias, Ankur M Thomas, Davide Gianni, Maximilian Pistor

Neurol Neuroimmunol Neuroinflamm· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis.
Maud Bagnoud, Myriam Briner, Jana Remlinger, Ivo Meli, Sara Schuetz, Maximilian Pistor

Cells· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosis.
Lisa Thiele Née Schrewe, Kirsten Guse, Silvia Tietz, Jana Remlinger, Seray Demir, Maximilian Pistor

J Neuroinflammation· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis.
Robert Hoepner, Maud Bagnoud, Maximilian Pistor, Anke Salmen, Myriam Briner

Acta Neuropathol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intramuscular Testosterone Supplementation Ameliorates Depression in Hypogonadal Men: A Retrospective Study in an Outpatient Department.
Andrei Miclea, Marius Miclea, Maximilian Pistor, Katharina Stegmayer, Robert Hoepner

Pharmacopsychiatry· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,25-OH vitamin D and AKT-inhibition increase glucocorticoid induced apoptosis in a model of T-cell acute lymphoblastic leukemia (ALL).
Maximilian Pistor, Lisa Schrewe, Steffen Haupeltshofer, Andrei Miclea, Simon Faissner

Leuk Res Rep· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D supplementation differentially affects seasonal multiple sclerosis disease activity.
Andrei Miclea, Marius Miclea, Maximilian Pistor, Andreas Hoepner, Andrew Chan

Brain Behav· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis